+ Targeted Therapies | etiraRx Targeted Therapies | etiraRx Our pipeline of therapies targeting unmet needs in oncology

Our pipeline of therapies targeting unmet needs in oncology

etiraRx Programs

Our novel molecular platform is driving the development of first-in-class targeted therapies treating a broad range of tumors.

Targeted Oncology

Cancer

Drug

Non clinical

Pre-clinical

IND Studies

Phase 1

Metastatic Breast Cancer

ER+

ERX-315

ER+

TX-542

TNBC

ERX-41


Ovarian Cancer

ERX-41

ERX-208


Pancreatic Cancer

ERX-358


Glioblastoma

ERX-41

ERX-342